I have rich data. Now let me compile the full structured answer.
Empirical Antibiotic Coverage - Febrile Child <18 Months
Core Concept: Risk Stratification First
Not every febrile child under 18 months needs antibiotics. The decision is based on age, appearance, risk factors, and workup results. The key pathogens driving empirical decisions are:
- Streptococcus pneumoniae (most common in post-Hib vaccine era)
- E. coli / Gram-negative rods (UTI, urosepsis)
- Neisseria meningitidis (meningococcemia)
- Group B Strep / Listeria (more in <3 months)
- Herpes simplex virus (HSV) (neonates, <28 days)
Age-Based Decision Framework
1. Neonates (0-28 days) - Always start empirical antibiotics
Full septic workup + admit + empirical treatment regardless of appearance.
| Drug | Dose | Coverage |
|---|
| Ampicillin | 50 mg/kg IV every 8h | Group B Strep, Listeria, enterococci |
| Gentamicin | 4-5 mg/kg IV every 24h | Gram-negatives (E. coli, Klebsiella) |
| + Acyclovir | 20 mg/kg IV every 8h | If HSV suspected (vesicles, seizures, ALT rise) |
| Cefotaxime (alt for Gentamicin) | 50 mg/kg IV every 8h | Gram-negatives, CNS penetration |
Note: Ceftriaxone is avoided in neonates due to risk of bilirubin displacement.
2. Infants 1-3 Months (29-90 days) - Risk stratify, most get antibiotics
Use low-risk criteria (Rochester, Philadelphia, Boston, or Step-by-Step criteria) to decide:
Low-risk criteria (all must be met to defer antibiotics):
- Well-appearing, non-toxic
- No focal bacterial infection on exam
- WBC 5,000-15,000/mm³
- ANC <4000/mm³ (or <1500 by some criteria)
- UA negative
- No infiltrate on CXR if obtained
- CSF WBC <8/mm³
If low-risk criteria met + fully immunized + reliable follow-up:
- Can observe without antibiotics with close 24h follow-up
- Blood culture must be sent
If any high-risk features OR toxic-appearing:
| Drug | Dose | Coverage |
|---|
| Ampicillin | 50 mg/kg IV every 6h | Listeria, enterococci (still relevant at this age) |
| Ceftriaxone | 50-100 mg/kg IV/IM once daily | Gram-negatives, pneumococcus, meningococcus |
| Or Cefotaxime | 50 mg/kg IV every 6-8h | If meningitis suspected (better CNS penetration) |
| + Acyclovir | 20 mg/kg IV every 8h | If CSF pleocytosis + HSV risk (until PCR returns) |
3. Infants 3-18 Months - Selective empirical treatment (including this patient)
This is the group your 18-month patient is in. Post-pneumococcal vaccination era has significantly lowered occult bacteremia risk (now ~0.5-1% in vaccinated children).
START Empirical Antibiotics When:
| Clinical Scenario | Antibiotic of Choice | Dose |
|---|
| Toxic/ill-appearing child | Ceftriaxone IV/IM | 50-100 mg/kg/day |
| Suspected meningitis (neck stiffness, bulging fontanelle, photophobia, petechiae) | Ceftriaxone + Dexamethasone | Ceftriaxone 100 mg/kg/day; Dexa 0.15 mg/kg q6h × 4 days |
| UTI / Urosepsis (pyuria + fever, ill child) | Ceftriaxone IV | 50 mg/kg once daily |
| Pneumonia with distress | Ampicillin IV or Amoxicillin-Clavulanate | Ampicillin 50 mg/kg q6h IV |
| Febrile convulsion + signs of meningitis | Ceftriaxone immediately (before LP if LP is delayed) | 100 mg/kg IV |
| Petechiae + fever (meningococcemia) | Ceftriaxone immediately | 100 mg/kg IV stat |
| Incompletely immunized | Ceftriaxone | 50-100 mg/kg IV |
| Pre-treated with antibiotics (masks signs) | Ceftriaxone + LP | 100 mg/kg IV |
Do NOT Start Empirical Antibiotics When (for 3-18 months):
- Well-appearing, playful child
- Fully immunized (PCV13, Hib)
- No focal source of infection
- UA negative
- Fever source identified as viral (URTI, roseola, HHV-6)
- WBC <15,000 and ANC <4000
For This Specific Patient (18 months, febrile convulsion)
| Feature | Assessment |
|---|
| Febrile convulsion | Likely simple - source of fever drives antibiotic decision |
| Well-appearing post-ictally | Reassuring |
| No meningeal signs | Reassuring |
| Fully immunized | Lower SBI risk |
Antibiotic Decision Tree:
Febrile convulsion in 18-month child
|
+-----------+
| |
Well-appearing Toxic / meningeal signs
| |
Identify fever source START Ceftriaxone IV immediately
| 100 mg/kg + LP + admit
|
Viral source (URTI) --> No antibiotics
UTI (pyuria on UA) --> Ceftriaxone 50 mg/kg OD
Pneumonia on CXR --> Ampicillin/Amoxicillin
No source found --> Blood culture, close obs 24h
Incomplete immunization --> Ceftriaxone empirically
Meningitis Coverage - Doses for 8.8 kg Child
| Drug | Dose | Calculated | Route/Frequency |
|---|
| Ceftriaxone | 100 mg/kg/day | 880 mg/day (divide 12h = 440 mg q12h) | IV over 30 min |
| Ampicillin | 50 mg/kg q6h | 440 mg per dose | IV |
| Dexamethasone | 0.15 mg/kg q6h × 4 days | 1.32 mg per dose | IV - give 15 min BEFORE 1st antibiotic dose |
| Acyclovir (if HSV) | 20 mg/kg q8h | 176 mg per dose | IV over 1 hour |
Dexamethasone reduces hearing loss and neurological sequelae in bacterial meningitis (especially H. influenzae), but is most beneficial when given before or with the first antibiotic dose.
Quick Summary
| Age | Empirical Antibiotics? | Drug of Choice |
|---|
| 0-28 days | Always | Ampicillin + Gentamicin ± Acyclovir |
| 1-3 months | Usually (risk stratify) | Ampicillin + Ceftriaxone/Cefotaxime |
| 3-18 months (vaccinated, well-appearing) | Only if focal source or toxic | Ceftriaxone |
| 3-18 months (unimmunized or ill-appearing) | Yes | Ceftriaxone |
| Suspected meningitis (any age) | Immediately, do not delay | Ceftriaxone + Dexamethasone |
Source: Rosen's Emergency Medicine, Febrile Infant chapter; The Harriet Lane Handbook, 23rd Ed.